| dc.contributor.author |
Chitkara, Deepak |
|
| dc.contributor.author |
Mittal, Anupama |
|
| dc.date.accessioned |
2024-01-05T10:49:14Z |
|
| dc.date.available |
2024-01-05T10:49:14Z |
|
| dc.date.issued |
2023-06 |
|
| dc.identifier.uri |
https://www.sciencedirect.com/science/article/pii/S0024320523002552 |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13692 |
|
| dc.description.abstract |
Exosomes, as a nanocarrier for the co-delivery of biologicals and small anticancer molecules is yet in its infancy. Herein, we investigated hUCBMSC derived exosomes as a biogenic nanocarrier for the co-delivery of tumor suppressor miR-125a and microtubule destabilizing Docetaxel (DTX) to target the proliferative and migratory aggressiveness of the murine TNBC 4T1 cells. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Elsevier |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
MSC |
en_US |
| dc.subject |
Exosomes |
en_US |
| dc.subject |
Docetaxel |
en_US |
| dc.subject |
Metastasis |
en_US |
| dc.subject |
Multi-nucleation |
en_US |
| dc.title |
Human umbilical cord blood-mesenchymal stem cell derived exosomes as an efficient nanocarrier for Docetaxel and miR-125a: Formulation optimization and anti-metastatic behaviour |
en_US |
| dc.type |
Article |
en_US |